recent years, studies have shown that heparin binding protein (HBP) can also be used as an indirect biomarker for the early diagnosis of sepsis, because it positively correlated with the PCT level. 7 The combined detection of PCT and HBP serum levels can greatly improve the early diagnosis of sepsis. 8 Unfortunately, for viral infections, the clinical significance of CRP and PCT, as well as routine blood tests, is not obvious. Thus, clinical findings are likely to be misinterpreted and patients are likely to be misdiagnosed. [9] [10] [11] [12] [13] [14] However, serum amyloid A1 (SAA1) has superior sensitivity and specificity in the diagnosis of viral infection. 15 The introduction of SAA1 on the basis of CRP and PCT can greatly compensate for the shortcomings in the currently available viral infection detection methods and provide more valuable reference information for the identification of viral and bacterial infections as well as suitable treatment options. 16, 17 Therefore, the combined detection of PCT, CRP, HBP, and SAA1 can effectively improve the accuracy of the early diagnosis of infectious diseases.
Currently, CRP and PCT are widely used in clinical settings, whereas the use of SAA1 and HBP has not yet been popularized.
Time-resolved fluorescent immunoassay (TRFIA) is an ultra-micro
labeling methodology that can greatly improve the sensitivity and specificity of detection when combined with the biotin-avidin system (BA-TRFIA). 18 In this article, the serum levels of PCT, CRP, HBP, and SAA1 were detected by BA-TRFIA. Based on currently available clinical diagnostic information, an analysis was performed to illustrate the clinical application value of PCT, CRP, HBP, and SAA1 in different combinations using BA-TRFIA.
| MATERIAL S AND ME THODS

| Materials
PCT monoclonal antibodies 16B5 and 42, and SAA1 monoclonal antibodies VSA31 and VSA25 were purchased from HyTest, Finland. CRP monoclonal antibodies 005M and 239 were purchased from Meridian Life Science, Inc, Memphis, TN, USA HBP monoclonal antibodies 2H6
and 1E2 were purchased from Zhuhai Bomei Biotechnology Co., Ltd., Zhuhai, Guangdong, China. Streptavidin was purchased from SigmaAldrich, Merck KGaA, Darmstadt, Germany, and the Eu-Labelling kit was purchased from Guangzhou Darui Biotechnology Co., Ltd., Guangzhou, Guangdong, China. The DR6608 time-resolved fluorescent immunoassay analyzer was purchased from Guangzhou Foshan Daan Medical Equipment Co., Ltd., Foshan, Guangdong, China. 
| Serum collection
| Principle of the assay
This experiment combined the advantages of both the biotin-avidin immune amplification and the time-resolved fluoro-immunoassay, which is based on the double-antibody sandwich method.
Specifically, the capture antibody and the biotinylated detection antibody were conjugated to two antigenic determinants on the an- 
| BA-TRFIA assay
The capture antibody-coated 96-well plate was removed and main- 
| Clinical evaluation
The serum levels of PCT, CRP, HBP, and SAA1 in 150 healthy subjects 
| ROC curve analysis
The reliability of the BA-TRFIA is shown in Figure 1 and was lower than that for CLIA, but it was higher for PCT than that for CLIA by the BA-TRFIA.
F I G U R E 1
The ROC curves for PCT, CRP, HBP, and SAA1. The graph was prepared using IBM SPSS statistics 20.0
| Methodological comparison
The authenticity of each biomarker is shown in Table 2 . The sensitivity of PCT was the highest (99.65%), but its specificity was the lowest (66.67%) and its Youden's index was also low (0.66). The specificity of SAA1 was the highest (85.71%), but its negative predictive value (NPV) was low (28.13%). Although the NPV (23.94%) and the Youden's index (0.67) of CRP were low, the sensitivity, specificity, accuracy, and positive predictive value (PPV) were greater than 80%. Lastly, the sensitivity, accuracy, and PPV of HBP were approximately 98%, but the specificity, Youden's index, and NPV were low.
When two biomarkers were detected, the sensitivity and NPV of PCT+CRP, PCT+HBP, and PCT+SAA1 were all 100%. Furthermore, the accuracy and PPV were all greater than 97%, but the specificity was less than 50% and the Youden's index was less than 0.5. In addition, the Youden's index and NPV of CRP+HBP, CRP+SAA1, and HBP+SAA1 were unsatisfactory.
When three biomarkers were detected, the authenticity of PCT+CRP+HBP and PCT+HBP+SAA1 yielded similar results. The sensitivity and NPV were all 100%, but the specificity (33.33%) and the Youden's index (0.33) were poor. PCT+CRP+SAA1 and CRP+HBP+SAA1
also yielded similar results. The sensitivity and PPV were as high as 99.12%, but the specificity (50%) and the Youden's index (0.49) were higher than PCT+CRP+HBP and PCT+HBP+SAA1, but still lower.
When four biomarkers were detected, the rate of missed diagnosis and misdiagnosis was greatly reduced. Based on the results of 115 clinical specimens, each evaluation index was optimal. 
| Clinical verification
Analysis of the levels of PCT, CRP, HBP, and SAA1 in 115 clinical specimens is shown in Table 3 . The differential diagnosis of bacterial and viral infections can also be achieved by examining the SAA1/ CRP ratio. The occurrence of sepsis can be better predicted, and the severity of the condition can be better determined by the com- 
| D ISCUSS I ON
In this study, we found that none of the biomarkers were absolutely sensitive or specific, especially for infectious diseases with complex etiologies and multiple manifestations. Individually, PCT, CRP, HBP, and SAA1 have indispensable roles in the diagnosis and tracking of different infectious diseases. However, the combination of the four biomarkers renders the clinical diagnosis of infectious diseases more convenient and accurate. Therefore, the combined detection of PCT, CRP, HBP, and SAA1 can provide clinicians with a more reliable early diagnosis.
To improve the diagnostic accuracy, it was critical to develop a more sensitive approach. Based on the respective advantages of the time-resolved fluorescent immunoassay and the biotin-avidin system, this study combined the two approaches to develop the BA-TRFIA, which detected PCT, CRP, HBP, and SAA1. Due to the inherent shortcomings of this approach, the method could not simultaneously detect multiple biomarkers. Instead, the biomarkers were separately detected. However, with the popularity of automated instruments, this shortcoming can be largely ignored.
In this study, we evaluated the ROC curves and the authenticity-related indicators of PCT, CRP, HBP, and SAA1. By contrast, the ROC curve indicated that the order of the AUC values was PCT ˃ SAA1 ˃ CRP ˃ HBP > 0.8, and each biomarker had a certain accuracy. The BA-TRFIA yielded a higher AUC value for PCT than for CLIA; that is, PCT had a higher clinical diagnostic value than CLIA. However, the BA-TRFIA was less useful when detecting CRP. Unfortunately, we found that there were several deficiencies when individually detecting the biomarkers, including low sensitivity or specificity. Presently, the combined detection of the four biomarkers has been used clinically to improve the diagnostic rate of bacterial and viral infections. After comparing various combinations, we found that a combination of PCT, CRP, HBP, and SAA1 had the greatest clinical value. The clinical verification once again highlighted the importance and necessity of the combined detection of the four biomarkers. Therefore, it is our opinion that the combined detection of PCT, CRP, HBP, and SAA1 in evaluating patients for potential bacterial and viral infections contributes to the more timely and accurate diagnosis of infectious diseases, especially in the early stages of sepsis.
| CON CLUS IONS
In summary, the individual detection of PCT, CRP, HBP, and SAA1
had some value in the diagnosis of infectious diseases, but there was evidence of misdiagnoses and missed diagnoses. However, the combined detection of the four biomarkers improved the sensitivity and accuracy of the diagnosis in a timely and effective manner, especially for the early prediction of sepsis. In general, the combined detection of the four biomarkers improved the detection rate of infectious diseases, ensured the accuracy of the diagnosis, and enhanced the clinical application of the BA-TRFIA.
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